Share of Clicks for top 10 US Healthcare & Medical Medicines brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| cvs.com | 26.48 |
| lilly.com | 4 |
| ro.co | 3.77 |
| walgreens.com | 3.64 |
| telyrx.com | 2.92 |
| goodrx.com | 2.72 |
| hellowisp.com | 1.97 |
| wegovy.com | 1.74 |
| vyepti.com | 1.69 |
| treatmyuti.com | 1.65 |
| others | 49.42 |
- cvs.com - 26.48%
- lilly.com - 4%
- ro.co - 3.77%
- walgreens.com - 3.64%
- telyrx.com - 2.92%
- goodrx.com - 2.72%
- hellowisp.com - 1.97%
- wegovy.com - 1.74%
- vyepti.com - 1.69%
- treatmyuti.com - 1.65%
- others - 49.42%
Copyright © Adthena. All rights reserved.
In the healthcare PPC landscape, CVS dominates with 26.48% click share, while ‘others’ collectively hold 49.42%, showcasing diverse competition.
Share of Spend for the top 10 US Healthcare & Medical Medicines brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | cvs.com | lilly.com | ro.co | wegovy.com | goodrx.com | hellowisp.com | telyrx.com | treatmyuti.com | hims.com | forbes.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/08/01 | 12.05% | 4.75% | 7.65% | 2.69% | 1.85% | 1.67% | 3.06% | 2.08% | 2.34% | 2.18% |
| 2026/08/02 | 12.84% | 4.38% | 6.5% | 3.87% | 2.04% | 1.99% | 2.94% | 2.5% | 2.1% | 2.4% |
| 2026/08/03 | 10.91% | 6.05% | 7.48% | 3.74% | 2.04% | 2.08% | 3.55% | 2.4% | 1.98% | 2.4% |
| 2026/08/04 | 13.32% | 5.29% | 7.05% | 2.41% | 2.09% | 2.21% | 2.58% | 2.73% | 2.2% | 2.18% |
| 2026/08/05 | 13.7% | 5.55% | 5.93% | 3.8% | 2.46% | 1.77% | 3.23% | 1.73% | 2.61% | 1.54% |
| 2026/08/06 | 11.38% | 7.18% | 7.08% | 4.84% | 2.54% | 1.45% | 2.34% | 0.97% | 2.76% | 1.69% |
| 2026/08/07 | 13.27% | 7.82% | 6.26% | 4.64% | 2.75% | 1.84% | 2.13% | 2.06% | 2% | 2.26% |
| 2026/08/08 | 13.34% | 7.62% | 6.6% | 5.18% | 1.68% | 1.52% | 2.26% | 1.11% | 1.84% | 3.08% |
| 2026/08/09 | 15.92% | 7.17% | 5.7% | 5.45% | 2.74% | 1.96% | 2.41% | 2.46% | 2.06% | 2.07% |
| 2026/08/10 | 15.4% | 7.72% | 6.39% | 4.12% | 3.03% | 1.27% | 2.21% | 2.09% | 1.92% | 3.1% |
| 2026/08/11 | 14.32% | 7.62% | 5.98% | 4.14% | 2.66% | 2.11% | 2.7% | 2.42% | 2.22% | 2.37% |
| 2026/08/12 | 12.41% | 6.43% | 6.66% | 3.65% | 2.67% | 2.1% | 3.72% | 2.69% | 2.2% | 1.81% |
| 2026/08/13 | 13.06% | 7.05% | 6.31% | 3.74% | 2.91% | 3.01% | 3.62% | 2.43% | 2.26% | 1.77% |
| 2026/08/14 | 12.99% | 6.93% | 7.04% | 3.71% | 3.14% | 2.35% | 3.04% | 2.07% | 2.47% | 2.46% |
| 2026/08/15 | 10.59% | 7.05% | 7.57% | 3.88% | 2.85% | 2.1% | 4.06% | 1.55% | 2.03% | 2.34% |
| 2026/08/16 | 11.56% | 7.78% | 7.74% | 2.62% | 3.74% | 2.44% | 3.2% | 2.06% | 1.99% | 2.28% |
| 2026/08/17 | 11.28% | 7.66% | 7.45% | 4.72% | 3.91% | 2.5% | 3.2% | 1.68% | 1.98% | 2.46% |
| 2026/08/18 | 12.31% | 8.8% | 8.19% | 4.43% | 2.66% | 3.05% | 4.1% | 2.22% | 2.39% | 2% |
| 2026/08/19 | 11.49% | 9.65% | 8.76% | 4.73% | 2.69% | 1.63% | 3.52% | 1.12% | 2.38% | 1.8% |
| 2026/08/20 | 10.49% | 8.86% | 7.79% | 4.64% | 2.58% | 1.93% | 2.92% | 1.7% | 2.79% | 2.09% |
| 2026/08/21 | 11.11% | 9.14% | 8.77% | 4.79% | 2.57% | 1.31% | 2.67% | 1.44% | 2.22% | 2.12% |
| 2026/08/22 | 12.43% | 8.14% | 7.86% | 3.34% | 2.62% | 1.7% | 2.97% | 1.73% | 2.55% | 2.56% |
| 2026/08/23 | 13.61% | 7.66% | 7.45% | 3.76% | 2.49% | 1.99% | 3.13% | 1.88% | 2.11% | 2.1% |
| 2026/08/24 | 12.35% | 7.99% | 8.34% | 3.91% | 2.12% | 2.14% | 3.05% | 2.04% | 1.74% | 2.74% |
| 2026/08/25 | 12.94% | 7.98% | 7.12% | 4.46% | 3.15% | 2.26% | 2.72% | 2.08% | 1.89% | 2.12% |
| 2026/08/26 | 12.47% | 7.85% | 7.7% | 4.46% | 2.96% | 2.18% | 2.69% | 2.46% | 2.35% | 2% |
| 2026/08/27 | 12.13% | 7.61% | 8.7% | 4.92% | 3.2% | 1.81% | 2.32% | 1.98% | 2.54% | 2.12% |
| 2026/08/28 | 11.38% | 7.63% | 8.45% | 4.47% | 3.35% | 2.34% | 2.56% | 1.89% | 2.25% | 2.08% |
| 2026/08/29 | 10.43% | 8.25% | 7.57% | 4.18% | 3.87% | 2.07% | 2.22% | 1.91% | 2.06% | 2.44% |
| 2026/08/30 | 11.25% | 7.82% | 8.07% | 3.37% | 3.73% | 2.4% | 2.51% | 2.13% | 1.96% | 2.24% |
| 2026/08/31 | 12.64% | 8.87% | 7.12% | 4.26% | 3.72% | 2.87% | 2.68% | 2.08% | 1.82% | 1.59% |
- cvs.com
- lilly.com
- ro.co
- wegovy.com
- goodrx.com
- hellowisp.com
- telyrx.com
- treatmyuti.com
- hims.com
- forbes.com
Copyright © Adthena. All rights reserved.
In August 2026, CVS led with fluctuating spend shares, peaking mid-month. Lilly and Ro.co showed steady growth, while Wegovy and GoodRx had moderate increases. Hims and Forbes experienced minor fluctuations. The month ended with CVS maintaining dominance.
Competitor Count for US Healthcare & Medical Medicines
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/08/01 | 1823 |
| 2026/08/02 | 1806 |
| 2026/08/03 | 1780 |
| 2026/08/04 | 1839 |
| 2026/08/05 | 1648 |
| 2026/08/06 | 1587 |
| 2026/08/07 | 1527 |
| 2026/08/08 | 1458 |
| 2026/08/09 | 1465 |
| 2026/08/10 | 1515 |
| 2026/08/11 | 1569 |
| 2026/08/12 | 1543 |
| 2026/08/13 | 1548 |
| 2026/08/14 | 1541 |
| 2026/08/15 | 1529 |
| 2026/08/16 | 1497 |
| 2026/08/17 | 1514 |
| 2026/08/18 | 1458 |
| 2026/08/19 | 1444 |
| 2026/08/20 | 1491 |
| 2026/08/21 | 1484 |
| 2026/08/22 | 1489 |
| 2026/08/23 | 1489 |
| 2026/08/24 | 1509 |
| 2026/08/25 | 1450 |
| 2026/08/26 | 1478 |
| 2026/08/27 | 1493 |
| 2026/08/28 | 1501 |
| 2026/08/29 | 1511 |
| 2026/08/30 | 1485 |
| 2026/08/31 | 1449 |
Copyright © Adthena. All rights reserved.
August began with 1,823 advertisers, peaking at 1,839 on the 4th. A decline followed, reaching 1,444 by the 19th. The month concluded with 1,449 advertisers, reflecting a downward trend.
